Search Results - "Cirule, H"
-
1
Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine‐N‐oxide
Published in British journal of clinical pharmacology (01-11-2018)“…Aims Trimethylamine‐N‐oxide (TMAO) is a novel cardiovascular risk marker. We explored the association of commonly used cardiovascular medications with TMAO…”
Get full text
Journal Article -
2
Inhibition of L‐carnitine biosynthesis and transport by methyl‐γ‐butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction
Published in British journal of pharmacology (01-03-2015)“…Background and Purpose The important pathological consequences of ischaemic heart disease arise from the detrimental effects of the accumulation of long‐chain…”
Get full text
Journal Article -
3
Inhibition of L-carnitine biosynthesis and transport by methyl-[gamma]-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction
Published in British journal of pharmacology (01-03-2015)“…Background and Purpose The important pathological consequences of ischaemic heart disease arise from the detrimental effects of the accumulation of long-chain…”
Get full text
Journal Article -
4
Vasodilating and antiarrhythmic activity of heteryl lactones
Published in European journal of medicinal chemistry (01-10-1999)“…A new series of unsaturated γ- and δ-lactones with pyridyl, quinolyl and nitrophenyl substituents ( 9, 10) have been synthesized by the condensation of…”
Get full text
Journal Article -
5
The novel guanidine ME10092 protects the heart during ischemia–reperfusion
Published in European journal of pharmacology (07-06-2002)“…The novel guanidine N-(3,4-dimethoxy-2-chlorobenzylideneamino)-guanidine [ME10092; a metabolite to the strongly cardioprotective hydroxyguanidine…”
Get full text
Journal Article -
6
Cardioprotective effects of N‐hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats
Published in British journal of pharmacology (01-11-1999)“…The potential for the N‐hydroxyguanidine compound PR5 (N‐(3,4‐dimethoxy‐2‐chlorobenzylideneamino)‐N′‐hydroxyguanidine) as a cardioprotective agent in heart…”
Get full text
Journal Article